NextGenNK at NK2026
Members of the NextGenNK community participated in NK2026 in Monopoli, Italy, joining researchers from around the world to discuss the latest advances in NK cell biology, innate immunity, and translational immunotherapy research.
Researchers and partners from NextGenNK recently participated in NK2026, held in Monopoli, Italy on 22-25 September 2026. The meeting brought together leading scientists, clinicians, and industry representatives from across the globe to discuss the latest advances in NK cell biology, innate immunity, and NK cell-based immunotherapies.
During the conference, members of the NextGenNK community presented their latest research findings, participated in scientific discussions, and engaged with international collaborators working at the forefront of NK cell research. The meeting provided an important opportunity to share new knowledge, strengthen existing collaborations, and explore future research initiatives.
Participation at NK2026 reflects NextGenNK’s continued commitment to advancing innovative NK cell-based therapies and contributing to the international scientific community. Through active engagement in leading scientific conferences, NextGenNK helps accelerate the translation of cutting-edge research into future treatments for patients.